Skip to content

Orsiro 4.0/35/140Recalls & reported problems

Biotronik AG · Class 3 · Implant

All models of Orsiro (49)

Data updated Oct 16, 2026 from official FDA records · Editorial policy

Adverse event reports
1
Deaths reported
0
Injuries reported
0
Recalls naming it
0

Summary

The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 07640130439405), received between Jan 9, 2020 and Jan 9, 2020 — classified as 1 malfunction.

The most frequently reported specific device problem is “Device Dislodged or Dislocated” (1 report).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 16, 2026.

Most reported problems

Device problems

  • Device Dislodged or Dislocated1

Patient problems

  • No Consequences Or Impact To Patient1

Recent adverse event reports

The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.

  • MalfunctionJan 9, 2020Device Dislodged or Dislocated; Device Dislodged or Dislocated

    THE ORSIRO DRUG-ELUTING STENT SYSTEM WAS SELECTED TO TREAT A DISSECTION IN THE RCA BY DIRECT STENTING. AFTER DEPLOYING THE STENT AN IVUS WAS DONE AND DUE TO ARTIFACTS IN THE IVUS IMAGES IT WAS THOUGHT THAT THE STENT WAS NOT SEEN WELL. EVENTUALLY THE DISLODGED STENT WAS FOUND ON THE OPERATING TABLE.

    Patient problems: No Consequences Or Impact To Patient

    MAUDE report 9569424 ↗

Other Coronary drug-eluting stent devices

All Coronary drug-eluting stent devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page